GlassScriptPhysician profile
Robert A Follweiler
NPI 1033150636
$1,675.11
in general payments reported to CMS, 2019-2025
26 companies · $364 in 2025
The $364 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $480 · 2020: $235 · 2021: $130 · 2022: $154 · 2023: $180 · 2024: $133 · 2025: $364.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $677.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $676.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $215.22 | 2019-2021 | |
| Smith+Nephew, INC. | $168.77 | 2020-2025 | Evos, Q-Fix, Healicoil |
| Stryker Corporation | $150.99 | 2023-2025 | Pangea, Variax, Reunion |
| Djo, LLC | $144.96 | 2019-2025 | Cmf |
| Ermi LLC | $130.46 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $120.04 | 2020-2022 | |
| Orthogenrx INC. | $79.45 | 2019 | |
| Nevro Corp. | $78.70 | 2020-2023 | Senza |
| Collegium Pharmaceutical, INC. | $72.54 | 2023-2025 | Xtampza |
| Orthofix Medical, INC. | $62.81 | 2023-2025 | Physio-Stim, Accelstim |
| Si-Bone, INC. | $55.26 | 2019 | |
| Fidia Pharma USA INC. | $49.84 | 2019-2021 | |
| Biocomposites INC | $46.75 | 2025 | Stimulan |
| Coastal Medical Technologies LLC | $44.61 | 2023-2025 | |
| Avanos Medical | $41.40 | 2024 | Standard Rf Disposables, Grpro 2.1 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $29.67 | 2019-2021 | |
| Bioventus LLC | $26.50 | 2022 | |
| Spr Therapeutics, INC | $26.34 | 2024 | Sprint Pns System |
| Boston Scientific Corporation | $24.85 | 2023 | |
| Pacira Therapeutics, INC. | $22.59 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $17.13 | 2019 | |
| Kci USA, INC. | $16.32 | 2023 | Prevena, V.A.C. Dermatac, Activ.A.C. |
| Mvp Orthopedics INC | $15.72 | 2022 | |
| Carbofix Orthopedics INC | $15.18 | 2019 | |
| Heraeus Medical, LLC. | $9.68 | 2020 | |
| Kerecis Limited | $9.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Follweiler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.